Original Research
Published on 04 Nov 2024
Prognostic value of EMT-related genes and immune cell infiltration in thyroid carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1463258
- 112 views
Type at least 3 characters
6,516 articles
Articles
Original Research
Published on 04 Nov 2024
Single-cell sequencing unveils mitophagy-related prognostic model for triple-negative breast cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1489444
- 106 views
Original Research
Published on 04 Nov 2024
Identification of novel markers for neuroblastoma immunoclustering using machine learning
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1446273
- 124 views
Review
Published on 04 Nov 2024
Bladder cancer immune-related markers: diagnosis, surveillance, and prognosis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1481296
Original Research
Published on 04 Nov 2024
Dynamics trajectory of patient-reported quality of life and its associated risk factors among hepatocellular carcinoma patients receiving immune checkpoint inhibitors: a prospective cohort study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1463655
Original Research
Published on 04 Nov 2024
Single-cell RNA sequencing analysis identifies acute changes in the tumor microenvironment induced by interferon α gene therapy in a murine bladder cancer model
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1387229
Mini Review
Published on 04 Nov 2024
A comprehensive review of immune checkpoint inhibitor-related diabetes mellitus: incidence, clinical features, management, and prognosis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1448728
- 114 views
Original Research
Accepted on 01 Nov 2024
Cost-effectiveness analysis of benmelstobart, anlotinib, and chemotherapy in extensive-stage small-cell lung cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1477146
- 182 views
Original Research
Accepted on 01 Nov 2024
Effect of Hypoxia-induced mIL15 Expression on Expansion and Memory Progenitor Stem-like TILs in vitro
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1450245
Original Research
Accepted on 01 Nov 2024
Efficacy and safety of atezolizumab-bevacizumab vs pembrolizumab-lenvatinib in unresectable hepatocellular carcinoma: a retrospective, cohort study Short title：combination of ICIs and TKIs in treatment of HCC
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1472870
Original Research
Accepted on 01 Nov 2024
Single-Cell RNA Sequencing Reveals Key Molecular Drivers and Immune Landscape in Uveal Melanoma: Implications for Targeted Therapy and Prognostic Modeling
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1493752
Review
Accepted on 01 Nov 2024
Beclin-1: A Therapeutic Target at the Intersection of Autophagy, Immunotherapy, and Cancer Treatment
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1506426
Review
Published on 01 Nov 2024
Clinical immunotherapy in glioma: current concepts, challenges, and future perspectives
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1476436
- 329 views
Original Research
Published on 01 Nov 2024
The CRAFITY score emerges as a paramount prognostic indicator in hepatocellular carcinoma patients received Lenvatinib and Pembrolizumab
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1474456
- 254 views
Original Research
Published on 01 Nov 2024
The enhancement of immunoactivity induced by immunogenic cell death through serine/threonine kinase 10 inhibition: a potential therapeutic strategy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1451796
- 377 views
Review
Published on 01 Nov 2024
Deciphering the role of NcRNAs in Pancreatic Cancer immune evasion and drug resistance: a new perspective for targeted therapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1480572
- 157 views